Ac-225-PSMA-617
225Ac-PSMA-617 is the next generation of prostate cancer treatment following [...]
Ac-225-RYZ101
225Ac-RYZ101 (225Ac-DOTATATE) is the alpha-labeled analogue of 90Y- and 177Lu-DOTATATE. [...]
Lu-177-FAP-2286
177Lu-FAP-2286 (177Lu-3BP-2286) is a molecule from the FAPi family [...]
Sn-117m-DTPA
117mSn-DTPA was studied in the years 1990s as a bone [...]
Ra-224-RadSpherin
224Ra-RadSpherin is a suspension of Radium-224 in degradable calcium carbonate [...]
I-131-CAM-H2
131I-CAM-H2 (131I-SGMIB anti-HER2-VHH1) is a targeted radionuclide therapeutic drug (TRNT) [...]
I-131-Naxitamab
131I-Naxitamab (131I-3F8) is a murine antibody targeting GD2 (disialoganglioside), labeled [...]
Lu-177-EB-PSMA-617
177Lu-EB-PSMA-617 is a PSMA-617 analogue developed in China as an [...]
Lu-177-DOTA-EB-TATE
177Lu-DOTA-EB-TATE is a therapeutic agent based on the peptide octreotate [...]
Lu-177-CTT-1403
177Lu-CTT1403 is the therapeutic analogue of 18F-CTT1057, a phosphoramide based [...]